Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study.

Robert T Schooley; Peter Ruane; Robert A Myers; Gildon Beall; Harry Lampiris; Daniel Berger; Shan-Shan Chen; Michael D Miller; Erica Isaacson; Andrew K Cheng

doi:10.1097/00002030-200206140-00008

Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study.

Identifier:nobleid.org/w1/20260515/4F9EB8B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4F9EB8B2.svg?ark=w1%2F20260515%2F4F9EB8B2)](https://nobleid.org/work/w1/20260515/4F9EB8B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study.

Identifier:nobleid.org/w1/20260515/4F9EB8B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4F9EB8B2.svg?ark=w1%2F20260515%2F4F9EB8B2)](https://nobleid.org/work/w1/20260515/4F9EB8B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work